Betrixaban Patent Expiration

Betrixaban is Used for preventing blood clots and thrombosis. It was first introduced by Portola Pharmaceuticals Inc in its drug Bevyxxa on Jun 23, 2017.


Betrixaban Patents

Given below is the list of patents protecting Betrixaban, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Bevyxxa US8404724 Unit dose formulations and methods of treating thrombosis with an oral factor Xa inhibitor Mar 29, 2031 Portola Pharms Inc
Bevyxxa US8987463 Methods of synthesizing factor Xa inhibitors Dec 28, 2030 Portola Pharms Inc
Bevyxxa US8557852 Methods of using crystalline forms of a salt of a factor Xa inhibitor Sep 08, 2028 Portola Pharms Inc
Bevyxxa US7598276 Pharmaceutical salts and polymorphs of a factor Xa inhibitor Nov 08, 2026 Portola Pharms Inc
Bevyxxa US9555023 Pharmaceutical salts and polymorphs of a factor Xa inhibitor Nov 07, 2026 Portola Pharms Inc
Bevyxxa US6376515 Benzamides and related inhibitors of factor Xa Sep 15, 2020

(Expired)

Portola Pharms Inc
Bevyxxa US6835739 Benzamides and related inhibitors of factor Xa Sep 15, 2020

(Expired)

Portola Pharms Inc
Bevyxxa US8518977 Benzamides and related inhibitors of factor XA Sep 15, 2020

(Expired)

Portola Pharms Inc
Bevyxxa US8691847 Benzamides and related inhibitors of factor Xa Sep 15, 2020

(Expired)

Portola Pharms Inc
Bevyxxa US9629831 Benzamides and related inhibitors of factor XA Sep 15, 2020

(Expired)

Portola Pharms Inc



Betrixaban's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List